VSI HoloMedicine use in shunt surgeries

Recruiting

• Conditions: G91.2; Normal-pressure hydrocephalus

• Registration Number: DRKS00029708
• Lead Sponsor: eurochirurgie Asklepios Krankenhaus Altona

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-07-19
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Patients with dilated normal pressure hydrocephalus in whom elective hydrocephalus shunt placement is indicated;
Ventricular punctures via frontal burr hole trephines only; placement via mixed reality; informed consent; lateral ventricles displayable in VSI

Exclusion Criteria

Patients who explicitly refuse intraoperative use of VSI HoloMedicine; patients unable to gave consent

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To assess whether the use of the VSI HoloMedicine in shunt surgery could facilitate correct surgical insertion of the shunt for neurosurgeons, shorten the duration of surgery, and increase the safety of surgery.

Secondary Outcome Measures

Name	Time	Method
Preoperative:<br>Assessment of the accuracy of automatic segmentation of the ventricular system (especially the lateral ventricles) and manual corrections.<br><br>Intraoperative:<br>Assessment of the accuracy of the placement;<br>Estimation of comfort for the surgeon;<br>Estimated time savings in minutes;<br>Discontinuation of the use of the VSI HoloMedicine application;<br>Estimation of the increase in safety of the surgery due to the use of VSI HoloMedicine on the basis of the above-mentioned points.